Tissue transglutaminase IgA vs Anti-endomysial antibody: Key Differences

When it comes to diagnosing celiac disease, two important blood tests are often discussed: the tissue transglutaminase IgA antibody (anti-tTG) test and the anti-endomysial antibody (EMA) test. Understanding the differences between these tests can help you make sense of your lab results and discuss them with your healthcare provider.

What is tissue transglutaminase IgA (anti-tTG)?

Tissue transglutaminase IgA, or anti-tTG, is an antibody that your immune system may produce if you have celiac disease. Celiac disease is an autoimmune disorder where the ingestion of gluten leads to damage in the small intestine. The anti-tTG test measures the level of these antibodies in your blood. High levels suggest that your immune system is reacting to gluten, which is a hallmark of celiac disease. This test is commonly the first step in screening for celiac disease due to its high sensitivity.

What is anti-endomysial antibody (EMA)?

Anti-endomysial antibodies (EMA) are another type of antibody associated with celiac disease. Like anti-tTG, these antibodies are produced in response to gluten ingestion in individuals with celiac disease. The EMA test is highly specific, meaning it is very good at confirming a diagnosis of celiac disease when the result is positive. However, it is less commonly used as a first-line test because it is more expensive and requires a more complex testing process.

Why does it matter?

Understanding the differences between these tests is important because they serve different purposes in the diagnostic process. The anti-tTG test is often used for initial screening due to its high sensitivity - it is very good at identifying people who might have celiac disease. On the other hand, the EMA test is used to confirm a diagnosis because of its high specificity. A positive EMA test provides strong evidence for celiac disease. Together, these tests help provide a more complete picture and can guide further diagnostic steps, such as a biopsy of the small intestine.

How to interpret your results

If your anti-tTG test result is positive, it suggests that you may have celiac disease, and further testing, such as the EMA test or a biopsy, may be recommended. A positive EMA test result strongly indicates celiac disease, especially if you have symptoms like diarrhea, bloating, or weight loss. However, a negative result on either test does not entirely rule out celiac disease, especially if you have been on a gluten-free diet, which can lower antibody levels.

Frequently asked questions

What if my anti-tTG test is positive but my EMA test is negative?
This can happen, and your healthcare provider may consider other factors, including symptoms and additional tests, to make a diagnosis.

Can these tests be used for monitoring celiac disease?
Yes, these tests can help monitor how well your body is responding to a gluten-free diet by measuring changes in antibody levels over time.

Are these tests reliable for children?
Yes, both tests are reliable for diagnosing celiac disease in children, although your healthcare provider may choose the most appropriate test based on age and symptoms.

Can I have celiac disease with negative antibody tests?
It is possible but uncommon. A biopsy of the small intestine may be necessary for a definitive diagnosis if symptoms persist.

Do I need to eat gluten before taking these tests?
Yes, you should continue eating gluten before testing, as removing it from your diet can lower antibody levels and affect test results.

When to see a doctor

If you experience symptoms such as persistent diarrhea, bloating, or unexplained weight loss, or if you have a family history of celiac disease, it may be time to discuss testing with your healthcare provider. A positive result on either the anti-tTG or EMA test should prompt further discussion and possibly additional testing to confirm a diagnosis.

Remember, this information is for educational purposes and any decisions regarding your health should be made in consultation with your healthcare provider.